Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara)
Shots: Dong-A ST received EC approval for Imuldosa (DMB-3115), a biosimilar of Jan...
Lantern Pharma's LP-184 Gains the US FDA’s Fast-Track Designation to Treat TNBC
Shots: This designation is based on anti-tumor activity in 10 TNBC PDX models &...
Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease
Shots: The NMPA has approved Kisunla (donanemab-azbt) based on
GSK’s GSK’227 Secures the EMA’s Priority Medicines (PRIME) Designation for Extensive-Stage Small-cell Lung Cancer
Shots: The EMA has granted PRIME designation to GSK5764227 (GSK’227 or HS-20...
ViiV Healthcare Reports the CHMP’s Positive Opinion of Vocabria Plus Rekambys for HIV treatment
Shots: ViiV Healthcare (owned by GSK with Pfizer & Shionogi as shareholders) h...
Merck Reports the US FDA’s BLA Acceptance of Clesrovimab to Protect Infants from RSV Disease
Shots: The US FDA has accepted the BLA of clesrovimab (MK-1654) to protect infants...
